Siobhan O’Shea

2.8k total citations
62 papers, 1.7k citations indexed

About

Siobhan O’Shea is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Siobhan O’Shea has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 33 papers in Epidemiology and 29 papers in Virology. Recurrent topics in Siobhan O’Shea's work include HIV/AIDS Research and Interventions (32 papers), HIV Research and Treatment (27 papers) and HIV/AIDS drug development and treatment (18 papers). Siobhan O’Shea is often cited by papers focused on HIV/AIDS Research and Interventions (32 papers), HIV Research and Treatment (27 papers) and HIV/AIDS drug development and treatment (18 papers). Siobhan O’Shea collaborates with scholars based in United Kingdom, Canada and United States. Siobhan O’Shea's co-authors include J E Banatvala, Annemiek de Ruiter, Jane Mullen, J. E. Banatvala, J. M. Best, Philippa Easterbrook, Jennifer M. Best, I. L. Chrystie, Karen Corbett and Mark Zuckerman and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Siobhan O’Shea

62 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siobhan O’Shea United Kingdom 26 1.1k 794 672 153 152 62 1.7k
Barbara Suligoi Italy 24 1.1k 1.0× 1.2k 1.6× 613 0.9× 143 0.9× 136 0.9× 141 2.0k
Giovanni Rezza Italy 22 1.1k 1.0× 553 0.7× 637 0.9× 220 1.4× 71 0.5× 47 1.6k
Ann McDonald Australia 19 788 0.7× 692 0.9× 364 0.5× 138 0.9× 78 0.5× 41 1.3k
Nzila Nzilambi United States 17 1.0k 0.9× 529 0.7× 745 1.1× 116 0.8× 61 0.4× 22 1.5k
Mary M. Fanning Canada 23 854 0.8× 621 0.8× 394 0.6× 53 0.3× 61 0.4× 45 1.5k
Diana Antoniskis United States 14 1.1k 1.0× 964 1.2× 290 0.4× 130 0.8× 39 0.3× 20 1.6k
D. A. Cooper Australia 8 773 0.7× 666 0.8× 682 1.0× 115 0.8× 47 0.3× 15 1.4k
Jason F. Okulicz United States 23 1.3k 1.2× 707 0.9× 1.2k 1.7× 431 2.8× 88 0.6× 137 2.2k
Chris Verhofstede Belgium 31 1.8k 1.6× 600 0.8× 1.9k 2.8× 167 1.1× 69 0.5× 101 2.7k
Sharon Cassol United States 27 1.4k 1.3× 699 0.9× 1.3k 2.0× 294 1.9× 42 0.3× 48 2.2k

Countries citing papers authored by Siobhan O’Shea

Since Specialization
Citations

This map shows the geographic impact of Siobhan O’Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siobhan O’Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siobhan O’Shea more than expected).

Fields of papers citing papers by Siobhan O’Shea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siobhan O’Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siobhan O’Shea. The network helps show where Siobhan O’Shea may publish in the future.

Co-authorship network of co-authors of Siobhan O’Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Siobhan O’Shea. A scholar is included among the top collaborators of Siobhan O’Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siobhan O’Shea. Siobhan O’Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Tong, C. Y. William, Jonathan Hubb, Jane Mullen, et al.. (2015). Deep Sequencing of HIV-1 in Cerebrospinal Fluid: Table 1.. Clinical Infectious Diseases. 61(6). 1022–1025. 12 indexed citations
4.
Ruiter, Annemiek de, D Mercey, Jane Anderson, et al.. (2008). British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Medicine. 9(7). 452–502. 94 indexed citations
5.
Naglik, Julian R., S. P. Sweet, Robert W. Evans, et al.. (2006). Comparison of HIV-1 specific inhibitory activity in saliva and other human mucosal fluids.. Clinical and Vaccine Immunology. 1111–1118. 2 indexed citations
6.
Hawkins, David, Polly Clayden, Graham R. Foster, et al.. (2005). Guidelines for the management of HIV infection in pregnant women and the prevention of mother‐to‐child transmission of HIV. HIV Medicine. 6(S2). 107–148. 100 indexed citations
7.
Gupta, Ravindra K., I. L. Chrystie, Siobhan O’Shea, et al.. (2005). K65R and Y181C are less prevalent in HAART-experienced HIV-1 subtype A patients. AIDS. 19(16). 1916–1919. 32 indexed citations
8.
Mullen, Jane, Susan Leech, Siobhan O’Shea, et al.. (2002). Antiretroviral drug resistance among HIV‐1 infected children failing treatment. Journal of Medical Virology. 68(3). 299–304. 57 indexed citations
9.
Shaw, T R, Neil Berry, Cherelyn Vella, et al.. (2001). Antiretroviral Therapy for HIV-2 Infected Patients. Journal of Infection. 42(2). 126–133. 45 indexed citations
10.
Lyall, E. G. Hermione, Annemiek de Ruiter, David Hawkins, et al.. (2001). Guidelines for the management of HIV infection in pregnant women and the prevention of mother‐to‐child transmission. HIV Medicine. 2(4). 314–334. 61 indexed citations
11.
Lyall, E. G. Hermione, Julie Sheldon, Jane Mullen, et al.. (1999). Evidence for horizontal and not vertical transmission of human herpesvirus 8 in children born to human immunodeficiency virus-infected mothers. The Pediatric Infectious Disease Journal. 18(9). 795–799. 37 indexed citations
12.
Whitby, Denise, Nicola Smith, S. Matthews, et al.. (1999). Human Herpesvirus 8: Seroepidemiology among Women and Detection in the Genital Tract of Seropositive Women. The Journal of Infectious Diseases. 179(1). 234–236. 58 indexed citations
13.
O’Shea, Siobhan, et al.. (1994). Rubella reinfection; role of neutralising antibodies and cell-mediated immunity. Clinical and Diagnostic Virology. 2(6). 349–358. 15 indexed citations
14.
Thomas, H. I. J., P Morgan-Capner, J. E. Cradock‐Watson, et al.. (1993). Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: Implications for diagnosis and immunopathology. Journal of Medical Virology. 41(3). 196–200. 35 indexed citations
15.
Best, J. M., et al.. (1992). Rubella virus strains show no major antigenic differences.. PubMed. 34(3). 164–8. 15 indexed citations
16.
Castle, Valerie P., et al.. (1992). Induction of thrombospondin 1 by retinoic acid is important during differentiation of neuroblastoma cells.. Journal of Clinical Investigation. 90(5). 1857–1863. 25 indexed citations
17.
O’Shea, Siobhan, Jennifer M. Best, & J. E. Banatvala. (1992). A lymphocyte transformation assay for the diagnosis of congenital rubella. Journal of Virological Methods. 37(2). 139–147. 5 indexed citations
18.
Thomas, H. I. J., P Morgan-Capner, Gisela Enders, et al.. (1992). Persistence of specific IgM and low avidity specific IgG1 following primary rubella. Journal of Virological Methods. 39(1-2). 149–155. 38 indexed citations
19.
Martinꝉ, Roland, P Marquardt, Siobhan O’Shea, Martin Borkenstein, & Hans Wolfgang Kreth. (1989). Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. Journal of Neuroimmunology. 23(1). 1–10. 20 indexed citations
20.
O’Shea, Siobhan, J. M. Best, J E Banatvala, W. C. Marshall, & J. A. Dudgeon. (1984). Persistence of rubella antibody 8-18 years after vaccination.. BMJ. 288(6423). 1043–1043. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Suligoi Breakdown of academic impact, for papers by Giovanni Rezza Breakdown of academic impact, for papers by Ann McDonald Breakdown of academic impact, for papers by Nzila Nzilambi Breakdown of academic impact, for papers by Mary M. Fanning Breakdown of academic impact, for papers by Diana Antoniskis Breakdown of academic impact, for papers by D. A. Cooper Breakdown of academic impact, for papers by Jason F. Okulicz Breakdown of academic impact, for papers by Chris Verhofstede Breakdown of academic impact, for papers by Sharon Cassol
Rankless by CCL
2026